CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 56 enrolled
Drug / intervention
Theta burst stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02769312
NCT02769312Phase 2Completed
CompareCT.gov

Pilot Testing of Theta-Burst Neuromodulation for Chronic PTSD

VA Office of Research and Development·interventional·Posted May 11, 2016·Updated Mar 26, 2019

In Brief

A Phase 2 clinical trial evaluating Theta burst stimulation and Sham stimulation for Chronic Post-Traumatic Stress Disorder. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The purpose of the proposed study is to evaluate initial feasibility and efficacy of Theta Burst Transcranial Magnetic Stimulation (TBS) as an adjunct treatment for Veterans with PTSD. Primary outcomes measures include a feasibility of TBS procedures, with secondary outcome measures focusing on changes in PTSD symptom severity and quality of life and social/occupation functioning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Post-Traumatic Stress Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 11, 2016
Enrollment StartApr 1, 2016
Primary CompletionDec 19, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 10.1 years ago

Interventions

Theta burst stimulationdevice

Theta burst transcranial magnetic stimulation

Sham stimulationdevice

Sham Theta burst transcranial magnetic stimulation